Application Software

IFLYTEK

iFlytek Subsidiary iFlytek Medical Lists on HKEX, Parent Company 2025 Net Profit Surges 49.82%

iFLYTEK and China Mobile Jointly Launch 'Xinxi Xinghuo Smart Box'

IFLYTEK released FY2025 Q4 earnings on April 28 After-Market BJT, actual revenue CNY 10.12 B (forecast CNY 9.726 B), actual EPS CNY 0.3805 (forecast CNY 0.3449)

IFLYTEK released FY2026 Q1 earnings on April 28 After-Market (BJT), actual revenue CNY 5.274 B (forecast CNY 5.743 B), actual EPS CNY -0.07 (forecast CNY -0.0311)

IFLYTEK released FY2025 earnings on April 28 After-Market (BJT), actual revenue CNY 27.11 B (forecast CNY 27.34 B), actual EPS CNY 0.36 (forecast CNY 0.386)

IFLYTEK to Release FY2025 Annual Earnings on April 29 After-Market (BJT), Forecast Revenue CNY 27.34 B, EPS CNY 0.386

IFLYTEK to Release FY2026 Q1 Earnings on April 29 After-Market (BJT), Forecast Revenue CNY 5.743 B, EPS CNY -0.0311

iFlytek Unveils StarFire X2 Model, Focused on High-Professional Fields

iFLYTEK Subsidiary Beijing Xunfei Xiaoyi Technology Co., Ltd. Established

IFLYTEK released FY2025 Q3 earnings on October 20 After-Market (BJT), actual revenue CNY 6.078 B (forecast CNY 6.619 B), actual EPS CNY 0.0741 (forecast CNY 0.1166)

IFLYTEK released FY2025 9 Months Earnings on October 20 After-Market (BJT), actual revenue CNY 16.99 B, actual EPS CNY -0.0265

IFLYTEK to release FY2025 Q3 earnings on October 21 After-Market (BJT), forecast revenue CNY 6.634 B, EPS CNY 0.1166

Tianji Holdings Signs Strategic Partnership with Saudi Arabia's Ministry of Industry and Mineral Resources and iFlytek for Smart Manufacturing

IFLYTEK released FY2025 Semi-Annual Earnings on August 21 After-Market (BJT), actual revenue CNY 10.91 B, actual EPS CNY -0.1034

IFLYTEK released FY2025 Q2 earnings on August 21 After-Market BJT, actual revenue CNY 6.253 B (forecast CNY 6.881 B), actual EPS CNY -0.0207 (forecast CNY 0.0987)

IFLYTEK to Release FY2025 Semi-Annual Earnings on August 22, 2025 (BJT)

iFlytek Announces International Patent Application

Mayor Guo Wenhai of Zhongshan Meets with Huang Feiyun, Vice President of iFLYTEK

iFLYTEK Discusses Challenges and Advantages in Large Model Training with Domestic Chips

Controversy Arises from Hefei University of Technology President's Remarks

300212

002230

300229

301169

002368

The National Data Administration has released a draft for public comment on the "Implementation Plan for Promoting High-Quality Industry Dataset Construction Actions (Draft for Comments)". The plan aims to innovate business models for high-quality industry datasets, improve long-term operation mechanisms, encourage listings and trading on data exchanges, and develop diverse service forms such as "subscription model", "mall model", and "customization model"

Wallstreetcn

E-HUALU

Dataway

TAIJI CO.,LTD

National Data Administration: Plans to Explore New Trading Models Including Token Trading

IFLYTEK launches AstronClaw agent matrix; devices including iFlytek Office Notebook, AI glasses, and Guide01 robot have integrated Claw capabilities. (Jiemian)

688306

Peking University and BAAI jointly released the SpikePingpong algorithm, which was first deployed on Agibot Lingxi X2. The algorithm combines high-frequency spike vision and imitation learning, achieving precise perception and full-body coordinated control for robots in high-speed dynamic scenarios, providing a remote-free, fully autonomous ping-pong interaction experience

PIA Automation

Peking University and BAAI Jointly Release SpikePingpong Algorithm, First Deployed on Agibot Lingxi X2

Vietnam’s Viettel Telecom and China’s iFLYTEK have signed a strategic cooperation agreement to develop AI voice technologies for the Vietnamese market. The partnership will focus on creating Vietnamese-language speech technologies, integrating AI into hardware, and expanding into broader AI services. This collaboration aims to enhance speech processing, localization, and data security while optimizing performance on various devices. The agreement signifies the beginning of a long-term relationship to advance AI research and deployment in Vietnam.

TechNode

Vietnam’s Viettel Telecom, China’s iFLYTEK to jointly advance Vietnamese AI voice

003042

003008

"Two Instruments and Ten Thousand Phenomena" has completed a hundred million-level Series A financing, jointly led by Beijing Information Industry Development Investment Fund and Shunwei Capital, with participation from IFLYTEK, Legend Capital, and Yizhuang Guotou. This financing marks the company's entry into a stage of scaled development, and the funds will be used for complete machine research and development, core technology development, industrial ecosystem layout, and application scenario exploration

36Kr

SINO-AGRI UNION

KETOP

"Two Instruments and Ten Thousand Phenomena" completes hundreds of millions in Series A financing

02506

562600

159898

159883

CMB International Securities analyst Jill Wu has maintained a Buy rating on Xunfei Healthcare Technology Co., Ltd., setting a price target of HK$92.55. Despite a slight revenue trim due to slower government growth, the company showed strong double-digit expansion and improved operating leverage. Wu emphasizes the firm's growth potential in China's medical AI market, supported by favorable policies and client expansion in healthcare institutions. Her analysis justifies the Buy rating, reflecting confidence in Xunfei's long-term growth prospects.

- Analyst Wu Yongming from China Merchants Securities maintains a buy rating for iFlytek Medical Technology, setting a target price of 92.55 HKD.  
- The buy rating is supported by various factors related to iFlytek Medical's growth characteristics and strategic positioning in China's healthcare AI market, despite slight revenue declines due to slower government growth.  
- Wu highlights the rapid expansion of the customer base in grassroots healthcare and hospitals, aided by favorable policies for AI-assisted diagnosis and increasing contributions from patient services, suggesting resilience in long-term growth.

Tip Ranks

XUNFEIHEALTH

ChinaAMC CSI All Share Health Care Devices ETF

China Merchants CSI All Share Medical Apparatus and Instruments ETF

Maxwealth CSI All Share Medical Apparatus and Instruments ETF

Buy Rating on Xunfei Healthcare: Resilient Long-Term Growth from Expanding Medical AI Ecosystem Despite Near-Term Revenue Trim

On March 27th, iFLYTEK Medical released its performance report for the year 2025. During the reporting period, the company achieved operating revenue of 915 million yuan, a year-on-year increase of 25%; the annual loss was 65.77 million yuan, significantly narrowing compared to the previous year. At the performance briefing held on the evening of March 27th, Chairman Liu Qingfeng stated that the company is committed to promoting the intelligent transformation of hospitals

IFLYTEK Medical's revenue is expected to grow by 25% year-on-year in 2025

Xunfei Healthcare Narrows Loss as AI Medical Models Drive Revenue Growth in 2025

Xunfei Healthcare Narrows Loss as AI Medical Models Drive Revenue Growth in 2025

IFLYTEK(002230.SZ)

National Data Administration: Plans to Explore New Trading Models Including Token Trading

IFLYTEK launches AstronClaw agent matrix; devices including iFlytek Office Notebook, AI glasses, and Guide01 robot have integrated Claw capabilities. (Jiemian)

Peking University and BAAI Jointly Release SpikePingpong Algorithm, First Deployed on Agibot Lingxi X2

Vietnam’s Viettel Telecom, China’s iFLYTEK to jointly advance Vietnamese AI voice

"Two Instruments and Ten Thousand Phenomena" completes hundreds of millions in Series A financing

Buy Rating on Xunfei Healthcare: Resilient Long-Term Growth from Expanding Medical AI Ecosystem Despite Near-Term Revenue Trim

IFLYTEK Medical's revenue is expected to grow by 25% year-on-year in 2025

Xunfei Healthcare Narrows Loss as AI Medical Models Drive Revenue Growth in 2025